Half-dose versus half-fluence photodynamic therapy for chronic central serous chorioretinopathy

被引：0
|
作者：
Matoba, Ryo [1 ]
Shiode, Yusuke [1 ]
Kawata, Tetsuhiro [1 ]
Hosokawa, Mio [1 ]
Kimura, Shuhei [1 ]
Morizane, Yuki [1 ]
Shiraga, Fumio [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
647 photodynamic therapy; 585; macula/fovea; 462 clinical (human) or epidemiologic studies: outcomes/complications;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6376
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes
    Matuskova, Veronika
    Vyslouzilova, Daniela
    Uher, Michal
    SEMINARS IN OPHTHALMOLOGY, 2018, 33 (05) : 690 - 699
  • [22] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Mao, Jian-Bo
    Zhang, Cai-Yun
    Liu, Chen-Yi
    Zhang, Yun
    Lin, Jing-Jing
    Xu, Zhao-Kai
    Chen, Yi-Qi
    Fan, Yuan-Yuan
    Zhao, Shi-Xin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (05) : 719 - 724
  • [23] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Jian-Bo Mao
    Cai-Yun Zhang
    Chen-Yi Liu
    Yun Zhang
    Jing-Jing Lin
    Zhao-Kai Xu
    Yi-Qi Chen
    Yuan-Yuan Fan
    Shi-Xin Zhao
    Li-Jun Shen
    International Journal of Ophthalmology, 2021, 14 (05) : 719 - 724
  • [24] Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Alovisi, Camilla
    Piccolino, Felice Cardillo
    Nassisi, Marco
    Eandi, Chiara M.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [25] Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
    Fujita, Kyoko
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Imamura, Yutaka
    Tanaka, Etsuko
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1681 - 1687
  • [26] Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin
    Toeteberg-Harms, M.
    Kurz-Levin, M.
    Fleischhauer, J.
    Windisch, R.
    OPHTHALMOLOGE, 2011, 108 (10): : 947 - 951
  • [27] Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy
    Lim, S. H.
    Chang, W.
    Sagong, M.
    EYE, 2013, 27 (03) : 353 - 362
  • [28] Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients
    Feenstra, Helena M. A.
    van Dijk, Elon H. C.
    van Rijssen, Thomas J.
    Tsonaka, Roula
    Diederen, Roselie M. H.
    Schlingemann, Reinier O.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    OPHTHALMOLOGY RETINA, 2022, 6 (10): : 930 - 938
  • [29] COMPARISON OF EFFICACY AND SAFETY BETWEEN HALF-FLUENCE AND FULL-FLUENCE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Shin, Joo Young
    Woo, Se Joon
    Yu, Hyeong Gon
    Park, Kyu Hyung
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (01): : 119 - 126
  • [30] Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
    Alkin, Zeynep
    Perente, Irfan
    Ozkaya, Abdullah
    Alp, Dilek
    Agca, Alper
    Aygit, Ebru Demet
    Korkmaz, Selcuk
    Yazici, Ahmet Taylan
    Demirok, Ahmet
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 685 - 690
12345